| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/27/2009 | CA2715760A1 Solid preparation for oral administration |
| 08/27/2009 | CA2715192A1 Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
| 08/27/2009 | CA2714700A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | CA2714122A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 08/27/2009 | CA2713716A1 Modulators for amyloid beta |
| 08/27/2009 | CA2713412A1 Amide derivative and pharmaceutical composition containing the same |
| 08/27/2009 | CA2713184A1 2-aza-bicyclo[2.2.1]heptane derivatives |
| 08/27/2009 | CA2712640A1 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 08/27/2009 | CA2712228A1 4,5-dihydro-oxazol-2-yl amine derivatives |
| 08/27/2009 | CA2709907A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 08/26/2009 | EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093289A1 Knockout animal exhibiting anxiety-like behavior |
| 08/26/2009 | EP2093225A1 Process for preparing crystalline eletriptan hydrobromide form ß |
| 08/26/2009 | EP2093224A1 Process for preparing eletriptan hydrobromide form beta |
| 08/26/2009 | EP2093220A2 Inhibitors of fatty acid amide hydrolase |
| 08/26/2009 | EP2093217A1 Polymorph and solvates of aripiprazole |
| 08/26/2009 | EP2092936A2 Tamper-resistant oral opioid agonist formulations |
| 08/26/2009 | EP2091959A1 Improved peptide composition |
| 08/26/2009 | EP2091945A1 Novel inhibitors of glutaminyl cyclase |
| 08/26/2009 | EP2091943A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 08/26/2009 | EP2091942A1 Substituted pyrazinone derivatives for use as a medicine |
| 08/26/2009 | EP2091939A1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| 08/26/2009 | EP2091938A1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists |
| 08/26/2009 | EP2091933A1 Dihydrobenzofuranyl derivatives and methods of their use |
| 08/26/2009 | EP2091566A1 Combination treatments for alzheimer's disease and similar diseases |
| 08/26/2009 | EP2091556A2 G protein coupled receptors and uses thereof |
| 08/26/2009 | EP2091544A2 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 08/26/2009 | EP2091540A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. |
| 08/26/2009 | EP2091534A1 Azetidinone derivatives and methods of use thereof |
| 08/26/2009 | EP2091531A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 08/26/2009 | EP2091526A1 Treatment of pervasive developmental disorders |
| 08/26/2009 | EP2091521A1 Anticonvulsive pharmaceutical compositions |
| 08/26/2009 | EP1861105B1 Process for the preparation of galanthamine hydrobromide |
| 08/26/2009 | EP1756071B1 Benzoxazolone derivatives, processes for preparing them and their uses |
| 08/26/2009 | EP1711530B1 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 08/26/2009 | EP1677772B1 Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action |
| 08/26/2009 | EP1603910B1 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 08/26/2009 | EP1553083B1 Prostaglandin derivatives |
| 08/26/2009 | EP1539700B1 8-hydroxy quinoline derivatives |
| 08/26/2009 | EP1524270B1 Sulfur-containing proanthocyanidin oligomer composition and process for producing the same |
| 08/26/2009 | EP1506951B9 Method for the preparation of total salvianolic acid |
| 08/26/2009 | EP1501804B1 Isoquinoline derivatives mao-b inhibitors |
| 08/26/2009 | EP1485087B1 (+)-2- [1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione for use in treating psoriasis by oral administration |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | EP1282636B1 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 08/26/2009 | EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives |
| 08/26/2009 | EP1173431B2 Method for the preparation of citalopram |
| 08/26/2009 | CN201295060Y Adjustable medicine-filled pillow |
| 08/26/2009 | CN101516911A Humanized antibody against amyloid beta |
| 08/26/2009 | CN101516893A Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derevatives and their use in therapy |
| 08/26/2009 | CN101516888A Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 08/26/2009 | CN101516887A Thiazole pyrazolopyrimidines as CRF1 receptor antagonists |
| 08/26/2009 | CN101516886A Thiophene pyrazolopyrimidine compounds |
| 08/26/2009 | CN101516882A Selective antagonists of A2A adenosine receptors |
| 08/26/2009 | CN101516881A 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 08/26/2009 | CN101516875A CGRP receptor antagonists |
| 08/26/2009 | CN101516859A 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
| 08/26/2009 | CN101516849A 5-phenyl-nicotinamide derivatives |
| 08/26/2009 | CN101516823A Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 08/26/2009 | CN101516401A Biomarkers for Alzheimer's disease progression |
| 08/26/2009 | CN101516400A Therapeutic agent for acceleration of spinal nerve repair comprising ghrelin, derivative thereof or substance capable of acting on GHS-R1a as active ingredient |
| 08/26/2009 | CN101516399A Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivative thereof as active ingredient |
| 08/26/2009 | CN101516377A New medical use of triazine derivatives |
| 08/26/2009 | CN101516373A Medicament for the enhancement of cognitive function and neuroprotection |
| 08/26/2009 | CN101513517A Traditional Chinese medicine electuary for treating parkinson disease and senile dementia |
| 08/26/2009 | CN101513510A Traditional Chinese medicine compound preparation for treating spinal cord injury and method for preparing same |
| 08/26/2009 | CN101513498A Chinese medicament for treating sexual function obstacle of male |
| 08/26/2009 | CN101513493A Medicinal composition for treating insomnia, and preparation method thereof |
| 08/26/2009 | CN101513464A Medicament for relieving alcoholism and protecting liver and preparation method thereof |
| 08/26/2009 | CN101513463A Chinese medicine composition for relieving alcoholism and protecting liver and preparation method thereof |
| 08/26/2009 | CN101513461A A pill for treating cerebral apoplex and the sequela thereof |
| 08/26/2009 | CN101513459A Chinese medicament composition for treating insomnia and preparation method thereof |
| 08/26/2009 | CN101513456A Chinese medicinal composition for treating headache, preparation method and quality control method thereof |
| 08/26/2009 | CN101513436A Szechuan lovage rhizome-angelica total extract, preparation and application |
| 08/26/2009 | CN101513425A Antiepileptic effect and application of fructose-1,6-diphosphate and dehydroascorbate |
| 08/26/2009 | CN101513410A Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 08/26/2009 | CN100532374C Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing same |
| 08/26/2009 | CN100532370C Acylaminothiazole derivatives, their preparation and their use as inhibitor for producing beta starchy peptide |
| 08/26/2009 | CN100532369C Benzoxazine derivatives and uses thereof |
| 08/26/2009 | CN100532356C Sodium sulfonate substituted diphenyl heptane compound, and preparation method, and application |
| 08/26/2009 | CN100532349C Preparation of phenols difluoro heptane compound, and its oxidation resistant application |
| 08/26/2009 | CN100531743C Process for preparing Chinese herbal medicine yellow ligusticum and use |
| 08/26/2009 | CN100531738C Use of (11beta,17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579435 Somatostatin-dopamine chimeric analogs |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579375 (2R,7R)-7-Hydroxy-2-propyloctanoic acid, (2R,7S)-7-hydroxy-2-propyloctanoic acid and (2R)-8-hydroxy-2-propyloctanoic acid; treating agent for neurodegenerative diseases such as brain infarction and Alzheimer's disease |
| 08/25/2009 | US7579367 Aryl substituted pyridines and the use thereof |
| 08/25/2009 | US7579362 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579354 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro- 1H-purin-8-yl)- bicyclo[2.2.2]oct-1-yl]-propionic acid or pharmaceutically acceptable salts; highly potent and selective diuretics; treatment of cardiac and circulatory disorders, degenerative disorders of central nervous system |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579342 Pteridine compounds for the treatment of psoriasis |
| 08/25/2009 | US7579341 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 08/25/2009 | US7579188 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 08/25/2009 | CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/25/2009 | CA2368356C Patches containing buprenorphine hydrochloride |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |